This compound is primarily utilized in the pharmaceutical industry as an intermediate in the synthesis of various active pharmaceutical ingredients (APIs). Its structure, featuring a piperazine ring, makes it a valuable building block for developing drugs targeting neurological and psychiatric disorders. The presence of the tert-butyl group and methoxymethyl moiety enhances its stability and reactivity, allowing for precise modifications during drug development. It is often employed in the production of selective serotonin reuptake inhibitors (SSRIs) and other central nervous system (CNS) agents. Additionally, its chiral nature enables the creation of enantiomerically pure compounds, which are critical for optimizing drug efficacy and reducing side effects.